{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:54:05Z","timestamp":1777870445365,"version":"3.51.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-025-02379-2","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T14:39:10Z","timestamp":1756910350000},"page":"2929-2937","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response predictors and long-term outcomes of preprandial single-daily cyclosporine in children with steroid-dependent nephrotic syndrome"],"prefix":"10.1093","volume":"38","author":[{"given":"Yasuko","family":"Urushihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2957-3705","authenticated-orcid":false,"given":"Shuichiro","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daishi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Sakuraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ohtomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Masutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"2379_CR1","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1093\/ndt\/gfq318","volume":"25","author":"K Ishikura","year":"2010","unstructured":"Ishikura K, Yoshikawa N, Hattori S, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Yata N, Ando T, Honda M, for Japanese Study Group of Renal Disease in Children (2010) Treatment with microemulsified cyclosporine in children with frequently relapsing nephrotic syndrome. Nephrol Dial Transplant 25:3956\u20133962","journal-title":"Nephrol Dial Transplant"},{"key":"2379_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2215\/CJN.13071212","volume":"9","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Oba MS, Ito S, Hataya H, Tanaka R, Ohwada Y, Kamei K, Ishikura K, Yata N, Nozu K, Honda M, Nakamura H, Nagata M, Ohashi Y, Nakanishi K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (2014) Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial. Clin J Am Soc Nephrol 9:271\u2013278","journal-title":"Clin J Am Soc Nephrol"},{"key":"2379_CR3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00467-005-1932-7","volume":"20","author":"S Fujinaga","year":"2005","unstructured":"Fujinaga S, Kaneko K, Takada M, Ohtomo Y, Akashi S, Yamashiro Y (2005) Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome. Pediatr Nephrol 20:1359\u20131360","journal-title":"Pediatr Nephrol"},{"key":"2379_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1592\/phco.25.1.52.55617","volume":"25","author":"T Kusaba","year":"2005","unstructured":"Kusaba T, Konno Y, Hatta S, Fujino T, Yasuda T, Miura H, Sasaki H, Okabayashi J, Murao M, Sakurada T, Imai G, Shirai S, Kuboshima S, Shima Y, Ogimoto G, Sato T, Masuhara K, Kimura K (2005) More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome. Pharmacotherapy 25:52\u201358","journal-title":"Pharmacotherapy"},{"key":"2379_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10157-008-0112-z","volume":"13","author":"S Shirai","year":"2009","unstructured":"Shirai S, Yasuda T, Tsuchida H, Kuboshima S, Konno Y, Shima Y, Sato T, Hatta S, Masuhara K, Kimura K (2009) Preprandial microemulsion cyclosporine administration is effective for patients with refractory nephrotic syndrome. Clin Exp Nephrol 13:123\u2013129","journal-title":"Clin Exp Nephrol"},{"key":"2379_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10157-025-02636-5","volume":"29","author":"R Hamada","year":"2025","unstructured":"Hamada R, Kaku Y, Inaba A, Kaito H, Kimata T, Kondo S, Sako M, Sato M, Sugimoto K, Tanaka S, Nagaoka Y, Nozu K, Hashimoto J, Miura K, Yamamoto M, Kawai F, Maruyama S, Ishikura K (2025) A digest of the clinical practice guideline for pediatric idiopathic nephrotic syndrome 2020 updated: medical therapy. Clin Exp Nephrol 29:691\u2013701","journal-title":"Clin Exp Nephrol"},{"key":"2379_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","volume":"38","author":"Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, Wetzels J, Alhasan K, Banerjee S, Bhimma R, Bonilla-Felix M, Cano F, Christian M, Hahn D, Kang HG, Nakanishi K, Safouh H, Trachtman H, Xu H, Cook W, Vivarelli M, Haffner D; International Pediatric Nephrology Association","year":"2023","unstructured":"Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, Wetzels J, Alhasan K, Banerjee S, Bhimma R, Bonilla-Felix M, Cano F, Christian M, Hahn D, Kang HG, Nakanishi K, Safouh H, Trachtman H, Xu H, Cook W, Vivarelli M, Haffner D; International Pediatric Nephrology Association (2023) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 38:877\u2013919","journal-title":"Pediatr Nephrol"},{"key":"2379_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5414\/CNP67285","volume":"67","author":"FM Rasche","year":"2007","unstructured":"Rasche FM, Keller F, Kunze G, Boesler B, Czock D (2007) Single daily dose of cyclosporine in patients with primary glomerulonephritis and nephrotic syndrome. Clin Nephrol 67:285\u2013292","journal-title":"Clin Nephrol"},{"key":"2379_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1440-1797.2007.00773.x","volume":"12","author":"A Takeda","year":"2007","unstructured":"Takeda A, Horike K, Onoda H, Ohtsuka Y, Yoshida A, Uchida K, Morozumi K (2007) Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile. Nephrology (Carlton) 12:197\u2013204","journal-title":"Nephrology (Carlton)"},{"key":"2379_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10157-024-02497-4","volume":"28","author":"Japanese Society of Nephrology","year":"2024","unstructured":"Japanese Society of Nephrology (2024) Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023. Clin Exp Nephrol 28:473\u2013495","journal-title":"Clin Exp Nephrol"},{"key":"2379_CR11","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1053\/ajkd.2001.27692","volume":"38","author":"AS Chishti","year":"2001","unstructured":"Chishti AS, Sorof JM, Brewer ED, Kale AS (2001) Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Am J Kidney Dis 38:754\u2013760","journal-title":"Am J Kidney Dis"},{"key":"2379_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00467-023-06108-4","volume":"39","author":"Y Takemasa","year":"2024","unstructured":"Takemasa Y, Fujinaga S, Nakagawa M, Sakuraya K, Hirano D (2024) Adult survivors of childhood-onset steroid-dependent and steroid-resistant nephrotic syndrome treated with cyclosporine: a long-term single-center experience. Pediatr Nephrol 39:473\u2013482","journal-title":"Pediatr Nephrol"},{"key":"2379_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5414\/CNP69084","volume":"69","author":"S Fujinaga","year":"2008","unstructured":"Fujinaga S, Ohtomo Y, Someya T, Shimizu T, Yamashiro Y, Kaneko K (2008) Is single-daily low-dose cyclosporine therapy really effective in children with idiopathic frequent-relapsing nephrotic syndrome? Clin Nephrol 69:84\u201389","journal-title":"Clin Nephrol"},{"key":"2379_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00467-011-2076-6","volume":"27","author":"S Fujinaga","year":"2012","unstructured":"Fujinaga S, Hirano D, Murakami H, Ohtomo Y, Shimizu T, Kaneko K (2012) Nephrotoxicity of once-daily cyclosporine A in minimal change nephrotic syndrome. Pediatr Nephrol 27:671\u2013674","journal-title":"Pediatr Nephrol"},{"key":"2379_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10157-020-01976-8","volume":"25","author":"S Fujinaga","year":"2021","unstructured":"Fujinaga S, Nishino T, Urushihara Y (2021) Efficacy of once-daily cyclosporine in Japanese children with steroid-dependent minimal change nephrotic syndrome. Clin Exp Nephrol 25:213\u2013214","journal-title":"Clin Exp Nephrol"},{"key":"2379_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00467-010-1707-7","volume":"26","author":"S Fujinaga","year":"2011","unstructured":"Fujinaga S, Hirano D, Nishizaki N, Someya T, Ohtomo Y, Ohtsuka Y, Shimizu T, Kaneko K (2011) Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration. Pediatr Nephrol 26:479\u2013483","journal-title":"Pediatr Nephrol"},{"key":"2379_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s10157-018-1628-5","volume":"23","author":"A Mizutani","year":"2019","unstructured":"Mizutani A, Fujinaga S, Sakuraya K, Hirano D, Shimizu T (2019) Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome. Clin Exp Nephrol 23:244\u2013250","journal-title":"Clin Exp Nephrol"},{"key":"2379_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00467-006-0294-0","volume":"22","author":"S Fujinaga","year":"2007","unstructured":"Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K (2007) A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome. Pediatr Nephrol 22:71\u201376","journal-title":"Pediatr Nephrol"},{"key":"2379_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00431-012-1913-3","volume":"172","author":"S Fujinaga","year":"2013","unstructured":"Fujinaga S, Someya T, Watanabe T, Ito A, Ohtomo Y, Shimizu T, Kaneko K (2013) Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab. Eur J Pediatr 172:513\u2013518","journal-title":"Eur J Pediatr"},{"key":"2379_CR20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","volume":"8","author":"K Solez","year":"2008","unstructured":"Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M (2008) Banff 07 classification of kidney allograft pathology: updates and future directions. Am J Transplant 8:753\u2013760","journal-title":"Am J Transplant"},{"key":"2379_CR21","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00467-013-2736-9","volume":"29","author":"P Sureshkumar","year":"2014","unstructured":"Sureshkumar P, Hodson EM, Willis NS, Barzi F, Craig JC (2014) Predictors of remission and relapse in idiopathic nephrotic syndrome: a prospective cohort study. Pediatr Nephrol 29:1039\u20131046","journal-title":"Pediatr Nephrol"},{"key":"2379_CR22","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00467-024-06605-0","volume":"40","author":"CH Robinson","year":"2025","unstructured":"Robinson CH, Aman N, Banh T, Brooke J, Chanchlani R, Dhillon V, Langlois V, Levin L, Licht C, McKay A, Noone D, Parikh A, Pearl R, Radhakrishnan S, Rowley V, Teoh CW, Vasilevska-Ristovska JH, Parekh RS (2025) Prolonged remission after cyclophosphamide or tacrolimus treatment in childhood nephrotic syndrome: a cohort study. Pediatr Nephrol 40:1625\u20131634","journal-title":"Pediatr Nephrol"},{"key":"2379_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00467-010-1642-7","volume":"26","author":"S Fujinaga","year":"2011","unstructured":"Fujinaga S, Hirano D, Nishizaki N (2011) Early identification of steroid dependency in Japanese children with steroid-sensitive nephrotic syndrome undergoing short-term initial steroid therapy. Pediatr Nephrol 26:485\u2013486","journal-title":"Pediatr Nephrol"},{"key":"2379_CR24","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s40620-024-02076-6","volume":"37","author":"K Mohamad","year":"2024","unstructured":"Mohamad K, Zainal H, Abdul Rahim NA, Tengku Hussain TH (2024) Timing of relapse as a key indicator of steroid-sparing requirements in childhood idiopathic nephrotic syndrome. J Nephrol 37:2551\u20132559","journal-title":"J Nephrol"},{"key":"2379_CR25","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s00467-024-06286-9","volume":"39","author":"Y Inoki","year":"2024","unstructured":"Inoki Y, Nishi K, Osaka K, Kaneda T, Akiyama M, Sato M, Ogura M, Kamei K (2024) Association between the time of initial relapse and subsequent relapses in patients with childhood-onset idiopathic nephrotic syndrome. Pediatr Nephrol 39:2393\u20132401","journal-title":"Pediatr Nephrol"},{"key":"2379_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00467-024-06461-y","volume":"40","author":"T Morishita","year":"2025","unstructured":"Morishita T, Fujinaga S, Sakuraya K (2025) Necessity of cyclosporine for minimal change disease with transient remission during initial 4-week prednisolone treatment: is it steroid-sensitive or steroid-resistant nephrotic syndrome? Pediatr Nephrol 40:265\u2013266","journal-title":"Pediatr Nephrol"},{"key":"2379_CR27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s10157-013-0925-2","volume":"18","author":"Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Shuto H, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y; Refractory Nephrotic Syndrome Study Group","year":"2014","unstructured":"Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Shuto H, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y; Refractory Nephrotic Syndrome Study Group (2014) Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial. Clin Exp Nephrol 18:784\u2013794","journal-title":"Clin Exp Nephrol"},{"key":"2379_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10157-017-1443-4","volume":"22","author":"S Shirai","year":"2018","unstructured":"Shirai S, Imai N, Sueki S, Matsui K, Tominaga N, Sakurada T, Yasuda T, Kimura K, Shibagaki Y (2018) Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial. Clin Exp Nephrol 22:283\u2013290","journal-title":"Clin Exp Nephrol"},{"key":"2379_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00467-014-2955-8","volume":"30","author":"Ishikura K, Yoshikawa N, Nakazato H, Sasaki S, Nakanishi K, Matsuyama T, Ito S, Hamasaki Y, Yata N, Ando T, Iijima K, Honda M; Japanese Study Group of Renal Disease in Children","year":"2015","unstructured":"Ishikura K, Yoshikawa N, Nakazato H, Sasaki S, Nakanishi K, Matsuyama T, Ito S, Hamasaki Y, Yata N, Ando T, Iijima K, Honda M; Japanese Study Group of Renal Disease in Children (2015) Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial. Pediatr Nephrol 30:459\u2013468","journal-title":"Pediatr Nephrol"},{"key":"2379_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00467-024-06342-4","volume":"39","author":"S Fujinaga","year":"2024","unstructured":"Fujinaga S (2024) Pre-emptive rituximab administration for discontinuation of steroid-sparing agents in patients with complicated frequently-relapsing or steroid-dependent nephrotic syndrome. Pediatr Nephrol 39:282","journal-title":"Pediatr Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02379-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-025-02379-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02379-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:59:42Z","timestamp":1777564782000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/9\/2929\/8462644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2379"],"URL":"https:\/\/doi.org\/10.1007\/s40620-025-02379-2","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects of the Ministry of Health, Labour and Welfare of Japan. This study was approved by the Ethics Committee of Saitama Children\u2019s Medical Center (approval no. 2023\u201301-008\u2013001) and Saitama Medical Center, Saitama Medical University (approval no. 2024\u2013044).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The presents study complies with the guidelines for human studies. This study does not contain any studies with animals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"The Institutional Review Board waived the requirement for informed consent due to the retrospective nature of this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}